glp-1 drugs kidney disease Real-World Evidence for Receptor Agonists Across the CKD Spectrum – AJKD Blog SGLT2 vs GLP-1 for CKD:

Kavyani Z, Shahhosseini E, Moridpour AH, Falahatzadeh M, Vajdi M, Musazadeh V, et al

Your journey is yours to own, and there are partners like us ready to help you navigate it

Sabatino A, Cuppari L, Stenvinkel P, Lindholm B, Avesani CM

In the rest of this post, well explore what these medications do, how they could impact Parkinsons, and the steps being taken to evaluate their possible utility in Parkinsons

If you live with type 1 diabetes, chances are you've heard about GLP-1 medications Ozempic, Wegovy, Mounjaro mostly in the context of weight loss or type 2 diabetes

Endpoints will cover the standard pharmacokinetic profile, plus pharmacodynamic markers that include weight change